Home › Sosei Subsidiary Heptares Awarded $5.5M Research & Development Grant From The US National Institute On Drug Abuse
 

Keywords :   


Sosei Subsidiary Heptares Awarded $5.5M Research & Development Grant From The US National Institute On Drug Abuse

2015-09-30 08:19:49| drugdiscoveryonline News Articles

Sosei Group Corporation is pleased to announce that its wholly-owned subsidiary Heptares Therapeutics (“Heptares”) has been awarded a grant from the National Institute on Drug Abuse (NIDA), one of the US National Institutes of Health

Tags: research development national abuse

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »